Innovator Etfs Trust Etf Earnings Per Share
| INOV Etf | USD 28.88 0.06 0.21% |
Innovator ETFs Trust fundamentals help investors to digest information that contributes to Innovator ETFs' financial success or failures. It also enables traders to predict the movement of Innovator Etf. The fundamental analysis module provides a way to measure Innovator ETFs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovator ETFs etf.
Innovator |
Innovator ETFs Trust ETF Earnings Per Share Analysis
Innovator ETFs' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Innovator ETFs Earnings Per Share | 0.34 X |
Most of Innovator ETFs' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovator ETFs Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Innovator ETFs Trust has an Earnings Per Share of 0.335 times. This is much higher than that of the Health Care Technology family and significantly higher than that of the Defined Outcome category. The earnings per share for all United States etfs is notably lower than that of the firm.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Innovator Fundamentals
| Return On Equity | 0.0716 | |||
| Return On Asset | 0.0331 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 7.22 B | |||
| Shares Outstanding | 77.17 M | |||
| Shares Owned By Insiders | 3.99 % | |||
| Shares Owned By Institutions | 75.85 % | |||
| Number Of Shares Shorted | 4.45 M | |||
| Price To Earning | 188.89 X | |||
| Price To Book | 8.31 X | |||
| Price To Sales | 8.25 X | |||
| Revenue | 667.52 M | |||
| Gross Profit | 499.7 M | |||
| EBITDA | 186.56 M | |||
| Net Income | 22.58 M | |||
| Cash And Equivalents | 128.63 M | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 897.3 M | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 2.17 X | |||
| Book Value Per Share | 4.91 X | |||
| Cash Flow From Operations | 146.36 M | |||
| Short Ratio | 6.78 X | |||
| Earnings Per Share | 0.34 X | |||
| Price To Earnings To Growth | 5.24 X | |||
| Target Price | 41.8 | |||
| Number Of Employees | 31 | |||
| Beta | 0.53 | |||
| Market Capitalization | 6.37 B | |||
| Total Asset | 1.97 B | |||
| Retained Earnings | 300.89 M | |||
| Working Capital | 158.8 M | |||
| Current Asset | 844.01 M | |||
| Current Liabilities | 67.53 M | |||
| One Year Return | 10.50 % | |||
| Net Asset | 1.97 B |
About Innovator ETFs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovator ETFs Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovator ETFs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovator ETFs Trust based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Innovator ETFs Piotroski F Score and Innovator ETFs Altman Z Score analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of Innovator ETFs Trust is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator ETFs' value that differs from its market value or its book value, called intrinsic value, which is Innovator ETFs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator ETFs' market value can be influenced by many factors that don't directly affect Innovator ETFs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator ETFs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator ETFs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator ETFs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.